Skip to content

Study · Not a test of the peptide alone · 2005

1 result

Synthesis of IL-2 mRNA in cells of rat hypothalamic structures after injection of short peptides.

Kazakova TB, Barabanova SV, Novikova NS, Glushikhina MS, Khavinson VKh, Malinin VV, Korneva EA

Bulletin of experimental biology and medicine1 Jun 2005Cited by 4 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Epitalon.

  1. 01AnimalNot a test of Epitalon aloneAnimal study (in vivo)Mechanism

    In rats, synthetic peptides including Epithalon modulated IL-2 gene expression in cells of some hypothalamic structures, depending on the terms and routes of administration.

    In plain wordsIn rats, short peptides including Epithalon changed IL-2 gene activity in some brain hypothalamus cells, depending on timing and route.

    Peptide
    Epitalon
    Outcome
    Direction not reportedIL-2 gene expression in hypothalamic cells
    Study

    ratn: not reported in source

    Rat hypothalamic structures (in situ hybridization)
    Outcome group
    Immune response · Nervous system and cognition

    Source sentences

    Summary
    In situ hybridization on paraffin sections of the rat brain showed that synthetic peptides Vilon, Epithalon, and Cortagen modulated the expression of IL-2 gene in vivo in cells of some hypothalamic structures depending on the terms and routes of administration.

    In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Epitalon.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 4 to 10Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 7 times, first on 21 Oct 2026, 17:05 UTC. The status did not change between them.

    Study results updated

  2. Version 3

    21 Oct 2026, 16:35 UTC

    Study data updated · source update from Europe PMC

  3. Version 2

    9 Oct 2026, 18:17 UTC

    Study results updated

  4. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.